AU2001274088A1 - Screening-method for modulators of methyltransferase-dependent chromosome stability - Google Patents

Screening-method for modulators of methyltransferase-dependent chromosome stability

Info

Publication number
AU2001274088A1
AU2001274088A1 AU2001274088A AU7408801A AU2001274088A1 AU 2001274088 A1 AU2001274088 A1 AU 2001274088A1 AU 2001274088 A AU2001274088 A AU 2001274088A AU 7408801 A AU7408801 A AU 7408801A AU 2001274088 A1 AU2001274088 A1 AU 2001274088A1
Authority
AU
Australia
Prior art keywords
modulators
suv39h2
screening
methyltransferase
chromosome stability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274088A
Inventor
Frank Eisenhaber
Thomas Jenuwein
Donal O'carroll
Stephen Rea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00112479A external-priority patent/EP1162460A1/en
Priority claimed from EP00112345A external-priority patent/EP1162274A1/en
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU2001274088A1 publication Critical patent/AU2001274088A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91005—Transferases (2.) transferring one-carbon groups (2.1)
    • G01N2333/91011—Methyltransferases (general) (2.1.1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Murine and human Suv39h2 polypeptide and DNA molecules encoding them. <i>Suv39h2</i> is a novel member of the <i>Suv3-9</i> gene family. Suv39h2 is a novel component of meiotic higher order chromatin. It has histone methyltransferase activity and is required, in combination with Suv39h1, for male gametogenesis. Sub39h2 can be used in screening methods to identify modulators of its methyltransferase activity, which are useful in cancer therapy and for male contraception.
AU2001274088A 2000-06-09 2001-06-07 Screening-method for modulators of methyltransferase-dependent chromosome stability Abandoned AU2001274088A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00112345 2000-06-09
EP00112479A EP1162460A1 (en) 2000-06-09 2000-06-09 Mammalian Suv39h2 proteins and isolated DNA molecules encoding them
EP00112345A EP1162274A1 (en) 2000-06-09 2000-06-09 Method for identifying compounds modifying methyltransferase-dependent chromosome stability
EP00112479 2000-06-09
PCT/EP2001/006485 WO2001094620A1 (en) 2000-06-09 2001-06-07 Screening-method for modulators of methyltransferase-dependent chromosome stability

Publications (1)

Publication Number Publication Date
AU2001274088A1 true AU2001274088A1 (en) 2001-12-17

Family

ID=26071033

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001274088A Abandoned AU2001274088A1 (en) 2000-06-09 2001-06-07 Screening-method for modulators of methyltransferase-dependent chromosome stability
AU2001266055A Abandoned AU2001266055A1 (en) 2000-06-09 2001-06-08 Screening method for modulators of suv39h2-methyltransferase

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001266055A Abandoned AU2001266055A1 (en) 2000-06-09 2001-06-08 Screening method for modulators of suv39h2-methyltransferase

Country Status (7)

Country Link
EP (2) EP1294927B1 (en)
JP (2) JP4896344B2 (en)
AT (1) ATE310100T1 (en)
AU (2) AU2001274088A1 (en)
DE (1) DE60115039T2 (en)
ES (1) ES2252240T3 (en)
WO (2) WO2001094620A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1459754A4 (en) * 2001-12-27 2005-08-31 Takeda Pharmaceutical Preventives/remedies for cancer
GB0301450D0 (en) * 2003-01-22 2003-02-19 Medical Res Council Protein crystal structure
JP3913181B2 (en) * 2003-02-06 2007-05-09 三菱重工業株式会社 Carbon nanofiber manufacturing method and manufacturing apparatus
JP5451376B2 (en) * 2007-03-15 2014-03-26 株式会社リバース・プロテオミクス研究所 Biomarkers specific for blood cell lineage or specific for osteoclast differentiation
JP6064231B2 (en) * 2011-06-03 2017-01-25 オンコセラピー・サイエンス株式会社 SUV39H2 as a target gene for cancer treatment and diagnosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2276474T3 (en) * 1997-08-29 2007-06-16 Innogenetics N.V. METHOD PEPTIDES, HOMOLOGOS OF THE SMD, THAT REACT WITH THE ANTIBODIES OF THE LIVES OF LIVING BEINGS AFFECTED WITH SYSTEMIC Erythematosus LUPUS.

Also Published As

Publication number Publication date
WO2001094621A1 (en) 2001-12-13
AU2001266055A1 (en) 2001-12-17
EP1294927B1 (en) 2005-11-16
JP2003535595A (en) 2003-12-02
DE60115039T2 (en) 2006-07-27
EP1294928A1 (en) 2003-03-26
JP2003535596A (en) 2003-12-02
DE60115039D1 (en) 2005-12-22
WO2001094620A1 (en) 2001-12-13
ES2252240T3 (en) 2006-05-16
ATE310100T1 (en) 2005-12-15
JP4896344B2 (en) 2012-03-14
EP1294927A1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
IL148512A0 (en) Methods for making recombinant proteins using apoptosis inhibitors
BRPI0412845A (en) herpes virus, use of a virus, pharmaceutical composition, and method of treating a tumor in an individual in need thereof
AU2905897A (en) Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
AU9582398A (en) Methods and devices for the long-term culture of hematopoietic progenitor cells
MXPA02007899A (en) Modified cytokines for use in cancer therapy.
HK1028615A1 (en) Isolated nona-and decapeptides which bind to hla molecules, and the use thereof
AU2003249227A1 (en) Methods and systems for extended in vitro culture of neuronal cells
GB9825096D0 (en) Cells,culture methods and their uses
AU2001274088A1 (en) Screening-method for modulators of methyltransferase-dependent chromosome stability
MX9703364A (en) Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof.
AU3522089A (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
AU2002251533A1 (en) Protein involved in restoration of cytoplasmic male sterility to fertility and gene encoding the protein and gene
WO2004041297A3 (en) Modified cytokines for use in cancer therapy
WO2001042431A3 (en) Regulation of human mitochondrial deformylase
AU2002230479A1 (en) Cell culture apparatus and methods of use
AU9694798A (en) T cell receptor-associated molecules (trams) and methods of use therefor
AU3028900A (en) Ras activator nucleic acid molecules, polypeptides and methods of use
AU2002353146A1 (en) Cell culture system and methods of use
AU2002360303A1 (en) Novel histone methyltransferase and methods of its use
AU1719199A (en) Two sterile-20 kinase-like proteins and methods of use thereof
AU2003241361A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU6430200A (en) Cyanobacterial strain of the genus nostoc, cultures, biomasses, extracts, bioactive molecules obtained therefrom and use thereof
AU9790398A (en) Mrit family of cell death proteins, nucleic acids encoding same, and methods of use
WO1994021273A3 (en) USE OF ANGIOGENINE, AND/OR α1-MICROGLOBULINE AND/OR COMPLEMENTARY FACTOR D FOR LIMITING PROTEIN SECRETION
AU2003222241A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof